Detalhe da pesquisa
1.
Ginsenoside Rg3 overcomes tamoxifen resistance through inhibiting glycolysis in breast cancer cells.
Cell Biol Int
; 48(4): 496-509, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38225685
2.
Risk factors for pegylated liposomal doxorubicin-induced moderate to severe hand-foot syndrome in breast cancer patients: assessment of baseline clinical parameters.
BMC Cancer
; 21(1): 362, 2021 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33827689
3.
The Cytochrome P450 Enzyme Responsible for the Production of (Z)-Norendoxifen in vitro.
Chem Biodivers
; 15(1)2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28834279
4.
Long non-coding RNA ANRIL promotes chemoresistance in triple-negative breast cancer via enhancing aerobic glycolysis.
Life Sci
; 306: 120810, 2022 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35850243
5.
Clinicopathologic significance of MYD88 L265P mutation and expression of TLR4 and P-STAT3 in primary central nervous system diffuse large B-cell lymphomas.
Brain Tumor Pathol
; 38(1): 50-58, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33079297
6.
High dose and hepatobiliary dysfunction are associated with hand-foot syndrome in patients with lymphoma using pegylated liposomal doxorubicin: a retrospective study.
BMC Pharmacol Toxicol
; 22(1): 63, 2021 10 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34696815
7.
An Immune-Related Gene Prognostic Index for Triple-Negative Breast Cancer Integrates Multiple Aspects of Tumor-Immune Microenvironment.
Cancers (Basel)
; 13(21)2021 Oct 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34771505
8.
Expressions of IFN-γ and IL-4 before and after Treatment of Lupus Nephritis with Traditional Chinese Medicine Combined with Cyclophosphamide and Their Values for Efficacy Prediction and Evaluation.
Iran J Public Health
; 49(5): 886-895, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32953676
9.
Apatinib-induced NF-κB inactivation sensitizes triple-negative breast cancer cells to doxorubicin.
Am J Transl Res
; 12(7): 3741-3753, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32774731
10.
A novel classification based on B-cell receptor signal gene expression correlates with prognosis in primary breast diffuse large B-cell lymphoma.
J Cancer
; 11(9): 2431-2441, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32201514
11.
RANKL and OPG Polymorphisms Are Associated with Aromatase Inhibitor-Related Musculoskeletal Adverse Events in Chinese Han Breast Cancer Patients.
PLoS One
; 10(7): e0133964, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26218592
12.
miRNA-24-3p promotes cell proliferation and inhibits apoptosis in human breast cancer by targeting p27Kip1.
Oncol Rep
; 34(2): 995-1002, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26044523
13.
Expression and correlation of matrix metalloproteinase-9 and heparanase in patients with breast cancer.
Med Oncol
; 31(7): 26, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24861922
14.
Overexpressions of microRNA-9 and microRNA-200c in human breast cancers are associated with lymph node metastasis.
Cancer Biother Radiopharm
; 28(4): 283-8, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23617747
15.
The expression and clinical significance of microRNA-1258 and heparanase in human breast cancer.
Clin Biochem
; 46(10-11): 926-32, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23415719
16.
High expression of CD147 and MMP-9 is correlated with poor prognosis of triple-negative breast cancer (TNBC) patients.
Med Oncol
; 30(1): 335, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23263825
17.
Indications of clinical and genetic predictors for aromatase inhibitors related musculoskeletal adverse events in Chinese Han women with breast cancer.
PLoS One
; 8(7): e68798, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23894347
18.
The expression and clinical significance of the androgen receptor and E-cadherin in triple-negative breast cancer.
Med Oncol
; 29(2): 526-33, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21519872
19.
Down-regulation of ICBP90 contributes to doxorubicin resistance.
Eur J Pharmacol
; 656(1-3): 33-8, 2011 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-21296067
20.
Immunological therapies can relieve aromatase inhibitor-related joint symptoms in breast cancer survivors.
Am J Clin Oncol
; 33(6): 557-60, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20124972